FY 1994 Financial Report
You can read this report in its original form here. Total Income for FY 93-94 was $106,650.48. There you have it, MAPS' financial report for FY 93-94. MAPS continues to grow as does its research agenda, …
MDMA
FY 1993 Financial Report
At the beginning of this fiscal year, MAPS had about 350 members and $897 in the bank. By the end of the fiscal year, MAPS' membership had doubled to 707 and its balance was $46,066 (consisting of …
FY 1992 Financial Report
You can read this report in its original form here. MAPS' total income in FY 91-92 was $28,859.55. The following categories had no expenditures this fiscal year. Public Relations/Ads, Salaries, Grants, …
Documents from the DEA Scheduling Hearing of MDMA, 1984-1988
1.Introduction to the Legal Record of the DEA’s 1984-1988 MDMA Scheduling Hearings DEA Announcement of proposed scheduling of MDMA as a Schedule I Drug, Federal Register, July 27, 1984 2. Before …
MDMA-Assisted Therapy Study Protocols
Phase 3 Trials: FDA Grants Breakthrough Therapy Designation for MDMA-Assisted Therapy for PTSD, Agrees on Special Protocol Assessment MAPS’ highest priority project is sponsoring Food and Drug Administration …